(Press-News.org) SAN DIEGO – Genetic sequencing technology is altering the way cancer is diagnosed and treated, but traditional specimen handling methods threaten to slow that progress.
That's the message delivered this week in a column appearing in the Journal of the American Medical Association (JAMA) by Scripps Clinic physicians Eric Topol, Kelly Bethel and Laura Goetz.
Dr. Topol is a cardiologist who serves as chief academic officer of Scripps Health and director of the Scripps Translational Science Institute (STSI), leading Scripps' genomic medicine research efforts. Dr. Bethel is a pathologist, and Dr. Goetz is a general surgeon and a researcher at STSI.
"Deciding how best to obtain (tumor) samples and how best to process them for whole genome or exome sequencing is a pivotal yet unresolved issue with several layers of complexity," the doctors wrote. "As the new clinical applicability of genomics emerges at a fairly rapid rate, the field of pathology will arrive at a tipping point for a fundamental change in how cancer specimens are handled."
Currently, tumor tissue obtained through a biopsy is fixed in formalin, a mixture of formaldehyde and water, and embedded in paraffin for microscopic viewing. However, because the chemical mixture damages DNA, sequencing tissue processed in this way can be difficult, if not impossible.
A better alternative is to also routinely freeze a portion of the specimen, which retains the tissue's genetic coding while preserving it for future analysis. In order to have enough tissue to freeze, larger or additional biopsy samples may be required, especially when using minimally invasive needle biopsy procedures.
"We need to completely rethink the way we have collected and stored cancer tissue samples for decades," said Dr. Topol, "It's becoming increasingly clear that obtaining an accurate map of a tumor's DNA can be the key to determining the specific mutations that are driving a person's cancer, how best to treat it and how likely it is to recur."
Even though complete genetic evaluations of tumors might require higher sample-storage costs and a more invasive biopsy procedure, most patients would likely agree to that option if it translates into a better diagnosis and possible treatment, the authors wrote.
Evidence of such benefit must come from randomized clinical trials that compare detailed genetic evaluation of tumor tissue with the current standard of care for cancer patients, they said.
"Drs. Goetz, Bethel and Topol's editorial acknowledges kindly the critical role pathologists play in patient care," said Dr. Stanley Robboy, president of the College of American Pathologists. "This type of change will require discussion about new operative standards, which will need the cooperation of surgeons, pathologists, ethicists and, of course, appropriate patient consents. It's these types of implications we will need to consider and incorporate as a progressive healthcare agenda is moved forward."
Patients and their advocates have a direct role to play in this transformation and should raise questions about tumor specimen storage and genetic testing with their doctor, said Dr. Topol, who outlines a consumer-led digital health revolution in his book "The Creative Destruction of Medicine."
INFORMATION:
ABOUT SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE
Part of San Diego, Calif.-based Scripps Health, the Scripps Translational Science Institute (STSI) is a unique community collaboration that initiates research that moves basic science from the lab to the patient bedside. STSI is supported by the NIH flagship program, Clinical and Translational Science Award (CTSA). Collaborators in the STSI consortium include Scripps Health, The Scripps Research Institute, the Burnham Institute for Medical Research, Children's Hospital of Philadelphia, Genomics Institute of the Novartis Research Foundation, The J. Craig Venter Institute, Salk Institute for Biological Studies, San Diego State University, San Diego Supercomputer Center and The Neurosciences Institute.
ABOUT SCRIPPS HEALTH
Founded in 1924 by philanthropist Ellen Browning Scripps, Scripps Health is a $2.6 billion nonprofit integrated health system based in San Diego, Calif. Scripps treats a half-million patients annually through the dedication of 2,600 affiliated physicians and 13,500 employees among its five acute-care hospital campuses, home health care services, and an ambulatory care network of physician offices and 23 outpatient centers and clinics.
Recognized as a leader in the prevention, diagnosis, and treatment of disease, Scripps is also at the forefront of clinical research, genomic medicine, wireless health care and graduate medical education. With three highly respected graduate medical education programs, Scripps is a longstanding member of the Association of American Medical Colleges and is recognized by Thomson Reuters for having one of the top teaching hospitals in the nation. Scripps is also the region's only cardiovascular program recognized by U.S. News & World Report as one of the best in the country. Scripps has been consistently recognized by Fortune, Working Mother magazine and AARP as one of the best places in the nation to work. More information can be found at www.scripps.org.
END
CAMBRIDGE, MA -- Many industrial plants depend on water vapor condensing on metal plates: In power plants, the resulting water is then returned to a boiler to be vaporized again; in desalination plants, it yields a supply of clean water. The efficiency of such plants depends crucially on how easily droplets of water can form on these metal plates, or condensers, and how easily they fall away, leaving room for more droplets to form.
The key to improving the efficiency of such plants is to increase the condensers' heat-transfer coefficient — a measure of how readily heat ...
Using brain scans of children and adults watching Sesame Street, cognitive scientists are learning how children's brains change as they develop intellectual abilities like reading and math.
The novel use of brain imaging during everyday activities like watching TV, say the scientists, opens the door to studying other thought processes in naturalistic settings and may one day help to diagnose and treat learning disabilities.
Scientists are just beginning to use brain imaging to understand how humans process thought during real-life experiences. For example, researchers ...
Researchers have uncovered a new way that some bacteria survive when under siege by antibiotics.
This survival mechanism is fundamentally different from other, known bacterial strategies. Understanding it may be useful for designing drugs that target hard-to-treat bacterial strains, such as drug-resistant tuberculosis, an increasingly urgent public health problem. The study is based on Mycobacterium smegmatis, a cousin of the microbe that causes TB, and its response to the TB drug isoniazid.
The research, by Yuichi Wakamoto of the University of Tokyo and Neeraj Dhar ...
LA JOLLA, CA – January 3, 2013 – Scientists at The Scripps Research Institute (TSRI) have achieved a feat in synthetic chemistry by inventing a scalable method to make complex natural compounds known as "polyhydroxylated steroids." These compounds, used in heart-failure medications and other drugs, have been notoriously problematic to synthesize in the laboratory.
The researchers demonstrated the new strategy by synthesizing ouabagenin [wa-bah-jenn-in], a close chemical cousin of ouabain, which Somali tribes once used as a potent poison on the tips of their arrows but ...
VIDEO:
By studying a set of fossil corals that are as much as 7,000 years old, scientists have dramatically expanded the amount of information available on the El Nino-Southern Oscillation, a...
Click here for more information.
By examining a set of fossil corals that are as much as 7,000 years old, scientists have dramatically expanded the amount of information available on the El Nino-Southern Oscillation, a Pacific Ocean climate cycle that affects climate worldwide. The ...
It's often difficult to completely eliminate a bacterial infection with antibiotics; part of the population usually manages to survive. We've known about this phenomenon for quite some time, dating back nearly to the discovery of penicillin. For more than 50 years, scientists have believed that the resistant bacteria were individuals that had stopped growing and dividing.
Up to now, in fact, it hasn't been possible to track the growth of cells before and after their exposure to antibiotics, which makes any analysis of the phenomenon quite imprecise. "Using microfluidics, ...
Washington, D.C.—After extensive analyses by a team of scientists led by Carl Agee at the University of New Mexico, researchers have identified a new class of Martian meteorite that likely originated from the Mars's crust. It is also the only meteoritic sample dated to 2.1 billion years ago, the early era of the most recent geologic epoch on Mars, an epoch called the Amazonian. The meteorite was found to contain an order of magnitude more water than any other Martian meteorite. Researchers from the Carnegie Institution (Andrew Steele, Marilyn Fogel, Roxane Bowden, and Mihaela ...
CORVALLIS, Ore. – Marine resource managers often gauge the health of species based on overall biomass, but a new study of predator-prey relationships in the Bering Sea found that it isn't the total number of individuals that predators care about – it's how densely they are aggregated.
It's more than searching for an easy meal, the researchers say. Predators need to balance how much energy they expend in searching for food with the caloric and nutrient value of that which they consume. When prey doesn't aggregate, however, the search for food becomes much more difficult ...
MADISON — A science-inclined audience and wide array of communications tools make the Internet an excellent opportunity for scientists hoping to share their research with the world. But that opportunity is fraught with unintended consequences, according to a pair of University of Wisconsin–Madison life sciences communication professors.
Dominique Brossard and Dietram Scheufele, writing in a Perspectives piece for the journal Science, encourage scientists to join an effort to make sure the public receives full, accurate and unbiased information on science and technology.
"This ...
JACKSONVILLE, Fla. — Researchers at Mayo Clinic in Florida have identified a new target to improve treatment of pancreatic ductal adenocarcinoma cancer, which accounts for more than 95 percent of pancreatic cancer cases. This fast-growing, often lethal cancer is resistant to conventional chemotherapy. The findings are published in the Jan. 3 online issue of PLOS ONE.
The researchers decoded a molecular pathway that is switched "on" at all times, promoting accelerated growth of pancreatic tumors, and that discovery revealed ways to disable the pathway. They say one strategy ...
